SML3095
SGC-BRDVIII-NC
≥98% (HPLC)
别名:
1,1-Dimethylethyl 4-[3-amino-6-(2-methoxyphenyl)-4-pyridazinyl]-1-piperazinecarboxylate, SGC-SMARCA-BRDVIII inactive control, SGC-SMARCA-BRDVIII negative control, tert-Butyl 4-[3-amino-6-(2-methoxyphenyl)pyridazin-4-yl]piperazine-1-carboxylate
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
Quality Level
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
SMILES string
O=C(N1CCN(CC1)C2=C(N)N=NC(C3=CC=CC=C3OC)=C2)OC(C)(C)C
InChI
1S/C20H27N5O3/c1-20(2,3)28-19(26)25-11-9-24(10-12-25)16-13-15(22-23-18(16)21)14-7-5-6-8-17(14)27-4/h5-8,13H,9-12H2,1-4H3,(H2,21,23)
InChI key
YOBVMDSDYHOOLN-UHFFFAOYSA-N
Biochem/physiol Actions
Inactive analog of and the negative control for the SMARCA2/4 and PB1(bromo 5)-selective SWI/SNF bromodomain inhibitor SGC-SMARCA-BRDVIII.
SGC-BRDVIII-NC is an inactive analog of and the recommended negative control for the potent, SMARCA2/4 and PB1(bromo 5)-selective SWI/SNF bromodomain (BRD) inhibitor SGC-SMARCA-BRDVIII.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Marek Wanior et al.
Journal of medicinal chemistry, 63(23), 14680-14699 (2020-11-21)
Accessibility of the human genome is modulated by the ATP-driven SWI/SNF chromatin remodeling multiprotein complexes BAF (BRG1/BRM-associated factor) and PBAF (polybromo-associated BAF factor), which involves reading of acetylated histone tails by the bromodomain-containing proteins SMARCA2 (BRM), SMARCA4 (BRG1), and polybromo-1.
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| SML3095-5MG | 04065266693171 |
| SML3095-25MG | 04065266693164 |